Qaytona is free while it's in beta — Get started

Ingredients

Nicotinamide Riboside

NR · Niagen · Nicotinamide Riboside Chloride

Snapshot

IndicationsContraindications
  • Arterial stiffness1
  • Werner syndrome1
  • Parkinson's disease2
  • Ataxia telangiectasia1, 3, 4
  • Neurodegeneration blood biomarkers5, 6
  • Heart failure inflammation7
  • Active malignancy8

Nicotinamide riboside (NR) is a vitamin B3 form converted to nicotinamide adenine dinucleotide (NAD+), a coenzyme in cellular energy metabolism, and oral intake raises blood NAD+ in humans9, 10. People take it to counter age-related NAD+ decline, with uses in arterial stiffness1, cognitive aging, Parkinson's disease2, and skeletal muscle function. The typical patient is a middle-aged or older adult9.

Oral NR reliably engages its target, but a systematic review found functional, metabolic, and vascular outcomes heterogeneous and often null11. Trials in mild cognitive impairment, subjective cognitive decline, and coronavirus disease 2019 (COVID-19) long-term symptoms raised NAD+ or biomarkers without improving cognition5, 12, 13. A meta-analysis did not support muscle preservation in adults over 6014. A 2026 retrospective cohort in glaucoma patients on stable topical therapy found visual field stabilization after combined NR and berberine, without a comparator group15. Products listing nicotinamide riboside number 275, nearly all capsules; see Form comparison.

A benefit/risk review flagged potential risks from raising NAD+, including tumorigenesis, toxic metabolites and cellular senescence, and long-term human data remain limited8.

Last updated October 15, 2026. Read how we make monographs.

In the full monograph

62 sources, 51 studies

  • When to useThe situations practitioners use it for, each with the reason and the study behind it.
  • SafetyWho should avoid it, who needs extra care, and the side effects reported in studies.
  • InteractionsThe medicines and supplements it interacts with, the effect of each, and what labeling says to watch.
  • Protocol notesThe doses used in studies, how and when they were taken, and how the forms on the market compare.
  • How it worksWhat it is and how it works in the body, in plain terms.
  • Published studiesThe studies behind each use, popular claims checked against them, and trials still under way.
  • Word of mouthWhat patients and practitioners report online, kept separate from the clinical evidence.
  • Clinical perspectiveA closing read of where the evidence is solid, where it is thin, and what has not been studied.

Sources

  1. 1Nicotinamide Riboside Supplementation Benefits in Patients With Werner Syndrome: A Double-Blind Randomized Crossover Placebo-Controlled Trial.pubmed.ncbi.nlm.nih.govShoji, Kato, Koshizaka et al. · Aging cell · 2025 · Pubmed
  2. 2The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson's disease.pubmed.ncbi.nlm.nih.govBrakedal, Dölle, Riemer et al. · Cell metabolism · 2022 · Pubmed
  3. 3Nicotinamide Riboside Improves Ataxia Scores and Immunoglobulin Levels in Ataxia Telangiectasia.pubmed.ncbi.nlm.nih.govVeenhuis, van Os, Janssen et al. · Movement disorders : official journal of the Movement Disorder Society · 2021 · Pubmed
  4. 4Long-Term Nicotinamide Riboside Use Improves Coordination and Eye Movements in Ataxia Telangiectasia.pubmed.ncbi.nlm.nih.govPresterud, Deng, Wennerström et al. · Movement disorders : official journal of the Movement Disorder Society · 2024 · Pubmed
  5. 5Cognitive and Alzheimer's disease biomarker effects of oral nicotinamide riboside (NR) supplementation in older adults with subjective cognitive decline and mild cognitive impairment.pubmed.ncbi.nlm.nih.govWu, Kupferschmid, Chen et al. · Alzheimer's & dementia (New York, N. Y.) · 2025 · Pubmed
  6. 6Oral nicotinamide riboside raises NAD+ and lowers biomarkers of neurodegenerative pathology in plasma extracellular vesicles enriched for neuronal origin.pubmed.ncbi.nlm.nih.govVreones, Mustapic, Moaddel et al. · Aging cell · 2023 · Pubmed
  7. 7Boosting NAD level suppresses inflammatory activation of PBMCs in heart failure.pubmed.ncbi.nlm.nih.govZhou, Wang, Qiu et al. · The Journal of clinical investigation · 2020 · Pubmed
  8. 8NAD+ therapy in age-related degenerative disorders: A benefit/risk analysis.pubmed.ncbi.nlm.nih.govBraidy, Liu · Experimental gerontology · 2020 · Pubmed
  9. 9Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults.pubmed.ncbi.nlm.nih.govMartens, Denman, Mazzo et al. · Nature communications · 2018 · Pubmed
  10. 10Safety and Metabolism of Long-term Administration of NIAGEN (Nicotinamide Riboside Chloride) in a Randomized, Double-Blind, Placebo-controlled Clinical Trial of Healthy Overweight Adults.pubmed.ncbi.nlm.nih.govConze, Brenner, Kruger · Scientific reports · 2019 · Pubmed
  11. 11NAD⁺ supplementation for anti-aging and wellness: A PRISMA-guided systematic review of preclinical and clinical evidence.pubmed.ncbi.nlm.nih.govGallagher, Emmanuel · Ageing research reviews · 2026 · Pubmed
  12. 12A randomized placebo-controlled trial of nicotinamide riboside in older adults with mild cognitive impairment.pubmed.ncbi.nlm.nih.govOrr, Kotkowski, Ramirez et al. · GeroScience · 2024 · Pubmed
  13. 13Effects of nicotinamide riboside on NAD+ levels, cognition, and symptom recovery in long-COVID: a randomized controlled trial.pubmed.ncbi.nlm.nih.govWu, Reynolds, Abril et al. · EClinicalMedicine · 2025 · Pubmed
  14. 14The Effect of Nicotinamide Mononucleotide and Riboside on Skeletal Muscle Mass and Function: A Systematic Review and Meta-Analysis.pubmed.ncbi.nlm.nih.govProkopidis, Moriarty, Bahat et al. · Journal of cachexia, sarcopenia and muscle · 2025 · Pubmed
  15. 15Mitochondrial Resilience in Glaucoma: Targeting NAD+ Metabolism and Oxidative Stress in Retinal Ganglion Cell Degeneration with Nicotinamide Riboside and Berberine: Preliminary Clinical Evidence.pubmed.ncbi.nlm.nih.govVisalli, Cappellani, Gagliano et al. · Diseases (Basel, Switzerland) · 2026 · Pubmed